EPRX
Price
$3.94
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
139.14M
62 days until earnings call
JWCTF
Price
$0.25
Change
+$0.09 (+56.25%)
Updated
May 29 closing price
Capitalization
96.54M
Interact to see
Advertisement

EPRX vs JWCTF

Header iconEPRX vs JWCTF Comparison
Open Charts EPRX vs JWCTFBanner chart's image
Eupraxia Pharmaceuticals
Price$3.94
Change-$0.00 (-0.00%)
Volume$11K
Capitalization139.14M
JW CAYMAN THERAPEUTICS
Price$0.25
Change+$0.09 (+56.25%)
Volume$57K
Capitalization96.54M
EPRX vs JWCTF Comparison Chart
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. JWCTF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and JWCTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (EPRX: $3.94 vs. JWCTF: $0.25)
Brand notoriety: EPRX and JWCTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 79% vs. JWCTF: 645%
Market capitalization -- EPRX: $139.14M vs. JWCTF: $96.54M
EPRX [@Biotechnology] is valued at $139.14M. JWCTF’s [@Biotechnology] market capitalization is $96.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileJWCTF’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • JWCTF’s FA Score: 1 green, 4 red.
According to our system of comparison, JWCTF is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 3 TA indicator(s) are bullish.

  • EPRX’s TA Score: 3 bullish, 5 bearish.

Price Growth

EPRX (@Biotechnology) experienced а +1.55% price change this week, while JWCTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

EPRX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EPRX($139M) has a higher market cap than JWCTF($96.5M). JWCTF YTD gains are higher at: 54.321 vs. EPRX (24.290).
EPRXJWCTFEPRX / JWCTF
Capitalization139M96.5M144%
EBITDA-25.89MN/A-
Gain YTD24.29054.32145%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash27.5MN/A-
Total Debt52.8KN/A-
TECHNICAL ANALYSIS
Technical Analysis
EPRX
RSI
ODDS (%)
Bearish Trend 5 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
40%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
57%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGEN4.280.75
+21.25%
Oragenics
AUTL2.340.08
+3.54%
Autolus Therapeutics plc
EBC14.930.37
+2.54%
Eastern Bankshares
FRD16.86-0.04
-0.24%
Friedman Industries Inc
NTRA163.76-1.75
-1.06%
Natera

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and CCCC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
N/A
CCCC - EPRX
29%
Poorly correlated
+17.69%
ETNB - EPRX
28%
Poorly correlated
+2.91%
ACAD - EPRX
28%
Poorly correlated
+3.00%
FDMT - EPRX
26%
Poorly correlated
+11.25%
ALEC - EPRX
26%
Poorly correlated
+5.67%
More

JWCTF and

Correlation & Price change

A.I.dvisor tells us that JWCTF and HSITF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JWCTF and HSITF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JWCTF
1D Price
Change %
JWCTF100%
N/A
HSITF - JWCTF
25%
Poorly correlated
N/A
HCWB - JWCTF
12%
Poorly correlated
+1.51%
SRZN - JWCTF
8%
Poorly correlated
-1.62%
INDP - JWCTF
5%
Poorly correlated
-1.04%
EPRX - JWCTF
4%
Poorly correlated
N/A
More